A human pharmacokinetic experiment found curcumin alone (2 g) produced undetectable or very low serum levels, while coadministration with a single 20 mg dose of piperine increased human bioavailability by a reported 2000%, with the effect appearing within 0.25 to 1 hour. Enhanced absorption with this specific low-dose piperine pairing is a formulation finding, not evidence of improved clinical outcomes, and does not show that other enhanced formulations behave the same way.[1]
- Small pharmacokinetic experiment with an unspecified human sample size; piperine-containing and other enhanced formulations (phospholipid complexes, nanoparticle/micellar curcumin) are not interchangeable.
- Abstract-checked; no qualified clinical review.
Inspection history
Clinical review: not reviewed by a qualified clinician.
· Independent source inspection; applicability narrowed and inherited assertions excluded where unsupported. No qualified clinical review.
· Reopened the PubMed structured abstract via E-utilities and added the exact reported bioavailability increases (rats +154%, humans +2000%) and timing. No PMC full text available. Independent editorial review pending; no qualified clinical review.